Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.

Takahiro Ushida,Yoichi Katayama, Yoichi Hiasa,Makoto Nishihara,Fumihiro Tajima,Shinsuke Katoh,Hirotaka Tanaka,Takeshi Maeda,Kazunari Furusawa, Mary Richardson,Yoshihiro Kakehi, Kunika Kikumori,Masanori Kuroha

Neurology（2022）

引用 4|浏览6

暂无评分

摘要

Mirogabalin elicited clinically relevant decreases in pain and was well-tolerated, suggesting that mirogabalin is a promising treatment for patients with CNeP due to SCI.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要